GENEVA, Oct. 27 -- SHINOBI THERAPEUTICS CO. LTD. (46-29, Yoshida-shimoadachicho, Sakyo-ku, Kyoto-shi, Kyoto6068304) filed a patent application (PCT/JP2025/014796) for "Cytotoxic Lymphocytes Expressing Variable Region-Deleted T Cell Receptors" on Apr 15, 2025. With publication no. WO/2025/220666, the details related to the patent application was published on Oct 23, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): KANEKO Shin (c/o Shinobi Therapeutics Co. Ltd. 46-29, Yoshida-shimoadachicho, Sakyo-ku, Kyoto-shi, Kyoto6068304), WANG Bo (c/o Shinobi Therapeutics Co. Ltd. 46-29, Yoshida-shimoadach...